| Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice SE Lamhamedi-Cherradi, SJ Zheng, KA Maguschak, J Peschon, ... Nature immunology 4 (3), 255-260, 2003 | 468 | 2003 |
| Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation BA Hilliard, N Mason, L Xu, J Sun, SE Lamhamedi-Cherradi, HC Liou, ... The Journal of clinical investigation 110 (6), 843-850, 2002 | 275 | 2002 |
| Modeling Ewing sarcoma tumors in vitro with 3D scaffolds ELS Fong, SE Lamhamedi-Cherradi, E Burdett, V Ramamoorthy, AJ Lazar, ... Proceedings of the National Academy of Sciences 110 (16), 6500-6505, 2013 | 264 | 2013 |
| Critical roles of tumor necrosis factor–related apoptosis-inducing ligand in type 1 diabetes SE Lamhamedi-Cherradi, S Zheng, RM Tisch, YH Chen Diabetes 52 (9), 2274-2278, 2003 | 175 | 2003 |
| Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function SJ Zheng, SE Lamhamedi-Cherradi, P Wang, L Xu, YH Chen Diabetes 54 (5), 1423-1428, 2005 | 149 | 2005 |
| Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice QS Mi, D Ly, SE Lamhamedi-Cherradi, KV Salojin, L Zhou, M Grattan, ... Diabetes 52 (8), 1967-1975, 2003 | 141 | 2003 |
| Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection ES Yolcu, N Askenasy, NP Singh, SEL Cherradi, H Shirwan Immunity 17 (6), 795-808, 2002 | 121 | 2002 |
| Transcriptional regulation of type I diabetes by NF-κB SE Lamhamedi-Cherradi, S Zheng, BA Hilliard, L Xu, J Sun, S Alsheadat, ... The Journal of Immunology 171 (9), 4886-4892, 2003 | 114 | 2003 |
| Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma M Santoro, SE Lamhamedi-Cherradi, BA Menegaz, JA Ludwig, AG Mikos Proceedings of the National Academy of Sciences 112 (33), 10304-10309, 2015 | 109 | 2015 |
| Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12 SE Lamhamedi-Cherradi, RE Martin, T Ito, F Kheradmand, DB Corry, ... The Journal of Immunology 180 (9), 6000-6009, 2008 | 81 | 2008 |
| Multimodality treatment of desmoplastic small round cell tumor: chemotherapy and complete cytoreductive surgery improve patient survival V Subbiah, SE Lamhamedi-Cherradi, B Cuglievan, BA Menegaz, ... Clinical Cancer Research 24 (19), 4865-4873, 2018 | 75 | 2018 |
| Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x SE Lamhamedi-Cherradi, JJ Luan, L Eloy, G Fluteau, JF Bach, ... Diabetologia 41, 178-184, 1998 | 73 | 1998 |
| IGF-1R and mTOR blockade: novel resistance mechanisms and synergistic drug combinations for Ewing sarcoma SE Lamhamedi-Cherradi, BA Menegaz, V Ramamoorthy, D Vishwamitra, ... JNCI: Journal of the National Cancer Institute 108 (12), djw182, 2016 | 54 | 2016 |
| Antagonist OX40 antibodies and their use in the treatment of inflammatory and autoimmune diseases LC Salah-Eddine, Y Zhengbin, S Sanjaya US Patent App. 12/526,550, 2010 | 54 | 2010 |
| 3D tissue-engineered model of Ewing's sarcoma SE Lamhamedi-Cherradi, M Santoro, V Ramammoorthy, BA Menegaz, ... Advanced drug delivery reviews 79, 155-171, 2014 | 53 | 2014 |
| CTLA-4−/− mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice ML Bergman, CM Cilio, C Penha-Gonçalves, SE Lamhamedi-Cherradi, ... Journal of autoimmunity 16 (2), 105-113, 2001 | 53 | 2001 |
| Further mapping of the Idd5. 1 locus for autoimmune diabetes in NOD mice SE Lamhamedi-Cherradi, O Boulard, C Gonzalez, N Kassis, D Damotte, ... Diabetes 50 (12), 2874-2878, 2001 | 51 | 2001 |
| An oral formulation of YK-4-279: preclinical efficacy and acquired resistance patterns in Ewing sarcoma SE Lamhamedi-Cherradi, BA Menegaz, V Ramamoorthy, RA Aiyer, ... Molecular cancer therapeutics 14 (7), 1591-1604, 2015 | 49 | 2015 |
| Identification and expression of a new type II transmembrane protein in human mast cells K Li, SW Wang, Y Li, RE Martin, L Li, M Lu, SE Lamhamedi-Cherradi, ... Genomics 86 (1), 68-75, 2005 | 47 | 2005 |
| Clinical activity of pazopanib in patients with advanced desmoplastic small round cell tumor BA Menegaz, B Cuglievan, J Benson, P Camacho, ... The oncologist 23 (3), 360-366, 2018 | 46 | 2018 |
Antonios G. MikosProfessor of Bioengineering and Chemical and Biomolecular Engineering, Rice UniversityVerified email at rice.edu
